Hope Neurology
Knoxville, Tennessee, United States
Neurologist in Knox County, Tennessee
2060 Lakeside Centre Wy, Knoxville, TN 37922
About Hope Neurology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
5
Genzyme, a Sanofi Company
3
Hoffmann-La Roche
3
Atara Biotherapeutics
1
Biogen
1
Genentech, Inc.
1
Jazz Pharmaceuticals
1
Clinical Trials at Hope Neurology
During the past decade, Hope Neurology conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on
average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
2007-08-01
2011-04-01
Completed
581
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
2007-10-01
2011-09-01
Completed
840
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
2009-08-01
2016-02-01
Completed
1,314
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
2015-10-16
2023-01-05
Completed
2,350
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-02-11
2019-05-03
Completed
608
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
2016-06-23
2017-10-20
Completed
22
Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
2017-10-19
2027-09-01
Active, not recruiting
134
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hope Neurology" #1 sponsor was "Celgene" with 5 trials, followed by "Genzyme, a Sanofi Company" with 3 trials
sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Atara Biotherapeutics" with 1 trials sponsored and "Biogen"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hope Neurology"
#1 collaborator was "Bayer" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hope Neurology
According to Clinical.Site data, the most researched conditions in "Hope Neurology" are
"Multiple Sclerosis" (6 trials), "Multiple Sclerosis, Relapsing-Remitting" (5 trials), "Multiple Sclerosis (MS)" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Primary Progressive Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Hope Neurology" in a lesser frequency.
Clinical Trials Intervention Types at Hope Neurology
Most popular intervention types in "Hope Neurology" are "Drug" (11 trials) and "Biological" (5 trials). Other intervention types were less common.
The name of intervention was led by "Interferon beta-1a" (3 trials), "Ocrelizumab" (3 trials), "Placebo" (3 trials), "Fenebrutinib" (2 trials) and "RPC1063" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hope Neurology
The vast majority of trials in "Hope Neurology" are
15 trials for "All" genders.
Clinical Trials Status at Hope Neurology
Currently, there are NaN active trials in "Hope Neurology".
undefined are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Hope Neurology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hope Neurology, 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".